Altamira Therapeutics (NASDAQ:CYTO) established a new business unit, OTC Consumer Health, to support the ongoing global roll out of Bentrio, its nasal spray for the protection against airborne viruses and allergens. OTC...
Closely-held Talkiatry, a provider of in-network psychiatric care, completed its $37-million Series A financing with an additional $17-million from Left Lane Capital. The latest round of funding comes just five months...
iBio (NYSE American:IBIO) updated progress on its lead COVID-19 vaccine program, IBIO-202, including a recently received the FDA response to its pre-IND package for IBIO-202. In light of the feedback received, the...
Results of a non-clinical research study demonstrated that Hepion Pharmaceuticals’ (NASDAQ:HEPA) clinical phase drug candidate, rencofilstat (CRV431), synergistically decreased liver tumor growth and extended mouse...
ENDRA Life Sciences (NASDAQ:NDRA) received Institutional Review Board approval from China’s Shanghai General Hospital for the first clinical study, expected to begin in 2022, of ENDRA’s Thermo Acoustic Enhanced...
Dyadic International (NASDAQ:DYAI) has engineered its C1-cell protein production platform to demonstrate the potential of manufacturing therapeutically viable and commercially useful cannabis compounds, including...
IntelGenx (TSX:IGX; OTCQB:IGXT) announced that patient dosing has resumed in the ongoing Phase 2a BUENA clinical trial in patients with mild-to-moderate Alzheimer’s disease (AD) under a previously amended protocol using...
PharmaJet’s needle-free Injection system will be used in a clinical trial to deliver a booster vaccine against COVID-19 virus variants. The vaccine developed by DIOSynVax, a spinoff company supported by the University...
Altamira Therapeutics (NASDAQ:CYTO), in a business update on its development activities in RNA therapeutics, appointed Covadonga Pañeda, Ph.D., as chief development officer for RNA therapeutics, effective in early April...
Absci (NASDAQ:ABSI), which uses deep learning AI and synthetic biology to expand the therapeutic potential of proteins, entered a research collaboration with Merck (known as MSD outside the U.S. and Canada), using...